to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Eggener, Scott E.
One or more keywords matched the following items that are connected to
Eggener, Scott E.
Neoplasms, Germ Cell and Embryonal
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
Clinical outcome and predictors of survival in late relapse of germ cell tumor.
Retroperitoneal lymph node dissection: reassessment of modified templates.
The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates.
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: current concepts and controversies.
Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.
Management of Low-Stage Testicular Seminoma.
Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database.
Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.
Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle.
Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors.
National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy.
Impact of Non-guideline-directed Care on Quality of Life in Testicular Cancer Survivors.
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
Robotic post-chemotherapy retroperitoneal lymph node dissection for testicular cancer: A multicenter collaborative study.
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
Neoplasms Germ Cell and Embryonal